Page 70 - Amgen News Today

Consolidated Planning Corp bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 728 shares of the medical research company’s stock, valued at approximately $210,000. Several other institutional investors and […]

Little House Capital LLC boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 8.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,190 shares of the medical research company’s stock after acquiring an additional 573 shares during the period. Little House Capital LLC’s […]

The Federal Reserve’s interest rate decision and Fed Chair Jerome Powell’s press conference are due on May 1

Callan Capital LLC raised its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 2,506 shares of the medical research company’s stock after acquiring an additional 137 shares during the period. Callan Capital LLC’s holdings in Amgen […]

Raab & Moskowitz Asset Management LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 773 shares of the medical research company’s stock after selling 136 shares during the quarter. Raab & Moskowitz Asset Management LLC’s holdings in Amgen were worth $223,000 […]

Raab & Moskowitz Asset Management LLC decreased its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 773 shares of the medical research company’s stock after selling 136 shares during the quarter. Raab […]

Raab & Moskowitz Asset Management LLC decreased its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 773 shares of the medical research company’s stock after selling 136 shares during the quarter. Raab […]

By Colin Kellaher Amgen plans to seek European regulatory approval for the sale of its blockbuster Tepezza treatment for thyroid eye disease. The Thousand Oaks, Calif., biotechnology...

MSFT earnings call for the period ending March 31, 2024.

Once again, Microsoft touted share gains as more and more customers used Azure's platforms and tools to build their own AI solutions.